These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24273690)

  • 1. Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.
    Mangalam A; Poisson L; Nemutlu E; Datta I; Denic A; Dzeja P; Rodriguez M; Rattan R; Giri S
    J Clin Cell Immunol; 2013 Jun; 4():. PubMed ID: 24273690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis.
    Poisson LM; Suhail H; Singh J; Datta I; Denic A; Labuzek K; Hoda MN; Shankar A; Kumar A; Cerghet M; Elias S; Mohney RP; Rodriguez M; Rattan R; Mangalam AK; Giri S
    J Biol Chem; 2015 Dec; 290(52):30697-712. PubMed ID: 26546682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosis.
    Datta I; Zahoor I; Ata N; Rashid F; Cerghet M; Rattan R; Poisson LM; Giri S
    bioRxiv; 2024 Feb; ():. PubMed ID: 38370675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Altered Metabolic Pathways during Disease Progression in EAE Mice via Metabolomics and Lipidomics.
    Lee G; Hasan M; Kwon OS; Jung BH
    Neuroscience; 2019 Sep; 416():74-87. PubMed ID: 31376423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target.
    Zahoor I; Suhail H; Datta I; Ahmed ME; Poisson LM; Waters J; Rashid F; Bin R; Singh J; Cerghet M; Kumar A; Hoda MN; Rattan R; Mangalam AK; Giri S
    Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2123265119. PubMed ID: 35700359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Plasma Metabolic Profiles in Chinese Patients With Multiple Sclerosis.
    Yang F; Wu SC; Ling ZX; Chao S; Zhang LJ; Yan XM; He L; Yu LM; Zhao LY
    Front Immunol; 2021; 12():792711. PubMed ID: 34975894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling blood-based brain biomarkers and cytokines in experimental autoimmune encephalomyelitis model of multiple sclerosis using single-molecule array technology.
    Zahoor I; Mir S; Giri S
    bioRxiv; 2023 Dec; ():. PubMed ID: 38234812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells.
    Qiu X; Guo Q; Liu X; Luo H; Fan D; Deng Y; Cui H; Lu C; Zhang G; He X; Lu A
    Front Pharmacol; 2018; 9():1237. PubMed ID: 30429789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.
    Dickens AM; Larkin JR; Davis BG; Griffin JL; Claridge TD; Sibson NR; Anthony DC
    J Neuroimmune Pharmacol; 2015 Sep; 10(3):435-44. PubMed ID: 26155956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic profiles in relapsing-remitting and progressive multiple sclerosis compared to healthy controls: a five-year follow-up study.
    Shi T; Browne RW; Tamaño-Blanco M; Jakimovski D; Weinstock-Guttman B; Zivadinov R; Ramanathan M; Blair RH
    Metabolomics; 2023 Apr; 19(5):44. PubMed ID: 37079261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
    Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
    J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
    Bing SJ; Ha D; Hwang I; Park E; Ahn G; Song JY; Jee Y
    Am J Chin Med; 2016; 44(6):1099-1110. PubMed ID: 27627913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal encephalopathy plasma metabolites are associated with neurodevelopmental outcomes.
    Friedes BD; Molloy E; Strickland T; Zhu J; Slevin M; Donoghue V; Sweetman D; Kelly L; O'Dea M; Roux A; Harlan R; Ellis G; Manlhiot C; Graham D; Northington F; Everett AD
    Pediatr Res; 2022 Aug; 92(2):466-473. PubMed ID: 34621028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
    Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
    Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icariin ameliorates the progression of experimental autoimmune encephalomyelitis by down-regulating the major inflammatory signal pathways in a mouse relapse-remission model of multiple sclerosis.
    Cong H; Zhang M; Chang H; Du L; Zhang X; Yin L
    Eur J Pharmacol; 2020 Oct; 885():173523. PubMed ID: 32871176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview.
    Zahoor I; Rui B; Khan J; Datta I; Giri S
    Cell Mol Life Sci; 2021 Apr; 78(7):3181-3203. PubMed ID: 33449145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.